Leukemia, B-Cell
Showing 9976 - 10000 of >10,000
Iron Overload, Sickle Cell Disease, Other Anemias Trial in Worldwide (Deferiprone, Deferoxamine)
Terminated
- Iron Overload
- +2 more
-
Oakland, California
- +32 more
Jul 16, 2021
Diffuse Large B Cell Lymphoma Relapsed, Diffuse Large B Cell Lymphoma Refractory Trial in United States (Ibrutinib, DA-EPOCH-R,
Completed
- Diffuse Large B Cell Lymphoma Relapsed
- Diffuse Large B Cell Lymphoma Refractory
- Ibrutinib
- +2 more
-
Duarte, California
- +9 more
Jan 14, 2019
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
NSCLC Trial in Worldwide (Lazertinib 240 mg/160 mg, Gefitinib 250 mg, Lazertinib-matching 240 mg/160 mg)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Lazertinib 240 mg/160 mg
- +3 more
-
Woolloongabba, Queensland, Australia
- +79 more
Nov 1, 2022
GI Motility Disorder Trial in Leuven (Corticotropin-release hormone)
Recruiting
- GI Motility Disorder
- Corticotropin-release hormone
-
Leuven, BelgiumI-Hsuan Huang
Oct 7, 2021
Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)
Recruiting
- Leukemia
- Melphalan
- +3 more
-
Cleveland, OhioUniversity Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022
Immunological Follow-up of Patients With Basedow's Orbitopathy
Completed
- Graves Orbitopathy
-
Montpellier, FranceUhmontpellier
Jan 10, 2022
Kidney Failure, Chronic, Chronic Kidney Disease stage3, Chronic Kidney Disease Stage 3B Trial in Lyon (Low-AGE diet, High-AGE
Not yet recruiting
- Kidney Failure, Chronic
- +5 more
- Low-AGE diet
- High-AGE diet
-
Lyon, FranceCentre Hospitalier Saint Joseph Saint Luc
Jan 3, 2022
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- (no location specified)
Aug 4, 2023
Lung Cancer Trial in Toulouse (Blood samples will be collected at two times before the treatment initiation:)
Not yet recruiting
- Lung Cancer
- Blood samples will be collected at two times before the treatment initiation:
-
Toulouse, France
- +1 more
Aug 3, 2023
Tumors, NUT Carcinoma Trial in Worldwide (BI 894999)
Completed
- Neoplasms
- NUT Carcinoma
- BI 894999
-
Boston, Massachusetts
- +15 more
Dec 3, 2021
Prostate Cancer Trial in Kelowna (Low dose rate prostate brachytherapy, High Dose Rate prostate brachytherapy)
Recruiting
- Prostate Cancer
- Low dose rate prostate brachytherapy
- High Dose Rate prostate brachytherapy
-
Kelowna, British Columbia, CanadaBritish Columbia Cancer Agency Center for the Southern Interior
Mar 3, 2022
Acute Myeloid Leukemia Leukemia Trial in Shanghai (MRX2843)
Not yet recruiting
- Acute Myeloid Leukemia Leukemia
-
Shanghai, Shanghai, ChinaJunmin Li,Ph.D
Jun 23, 2021
Spinal Cord Injuries Trial in Amman (Collection and expansion of BM-MSC, VI-SCI evaluation and patients' follow up)
Completed
- Spinal Cord Injuries
- Collection and expansion of BM-MSC
- VI-SCI evaluation and patients' follow up
-
Amman, JordanCell Therapy Center, University of Jordan
Aug 24, 2021
Hemophilia B Trial (VGB-R04)
Not yet recruiting
- Hemophilia B
- VGB-R04
- (no location specified)
Nov 29, 2021
Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)
Recruiting
- Hepatitis B Virus Infection
- Standard antiviral therapy
-
Changsha, Hunan, ChinaDepartment of Infectious Disease, Xiangya Hospital, Central Sout
May 22, 2022
DVT of Legs Trial in Hvidovre (Blood sample and Ultrasound examination)
Recruiting
- DVT of Legs
- Blood sample and Ultrasound examination
-
Hvidovre, Copenhagen, DenmarkCopenhagen University Hospital Hvidovre
Mar 15, 2023
Patients With Chronic Hepatitis B (CHB) Infection
Recruiting
- Hepatitis B
- +2 more
- All approved therapies for the treatment of Chronic Hepatitis B (CHB)
-
Phoenix, Arizona
- +30 more
Jan 27, 2023
Immunologic Deficiency Syndromes Trial in Milano (Strimvelis)
Enrolling by invitation
- Immunologic Deficiency Syndromes
- Strimvelis
-
Milano, Lombardia, ItalyOrchard Investigational Site
Jun 23, 2021
Study of Transfusion-Transmitted Infections
Completed
- Viral Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Bladder Cancer, Urothelial Carcinoma Bladder Trial in Mumbai (Adjuvant RT)
Recruiting
- Bladder Cancer
- Urothelial Carcinoma Bladder
- Adjuvant RT
-
Mumbai, Maharashtra, IndiaTata Memorial Centre
Oct 6, 2021
Oral Cavity Squamous Cell Carcinoma Trial in San Francisco (NisinZ® P, Surgery (non-interventional, standard of care))
Not yet recruiting
- Oral Cavity Squamous Cell Carcinoma
- NisinZ® P
- Surgery (non-interventional, standard of care)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 18, 2023
Migraine Trial in New York (PMR (Progressive muscle relaxation therapy), Monitored Usual Care (MUC))
Completed
- Migraine
- PMR (Progressive muscle relaxation therapy)
- Monitored Usual Care (MUC)
-
New York, New YorkNYU Langone
Sep 20, 2022
GVHD Trial in New Brunswick (Lactobacillus rhamnosus GG, laboratory biomarker analysis was not performed because of no
Completed
- Graft Versus Host Disease
- Lactobacillus rhamnosus GG
- laboratory biomarker analysis was not performed because of no differences in the clinical outcomes
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 23, 2021
NUT Midline Carcinoma (NMC), Triple Negative Breast Cancer (TNBC), NSCLC (NSCLC) Trial (Birabresib)
Terminated
- NUT Midline Carcinoma (NMC)
- +3 more
- (no location specified)
Jan 7, 2021